Mar 162016

Patients Paying $ 3 Billion for Wasted Cancer Drugs
To determine leftover doses, the report used projected data from federal Medicare claims and from the National Health and Nutrition Examination Survey. In 2016, insurers are expected to pay drug makers an extra $ 1.8 billion for cancer drugs which are …

and more »

health and nutrtion – read more